Inventor · disambiguated record
Zhiyuan Yang
Also filed as: YANG ZHIYUAN
13 granted patents·9 pending applications·54 citations·filing 2002–2025
89Inventor score
Files withEUREKA THERAPEUTICS INC13INVISISHIELD TECH LTD4MEMORIAL SLOAN KETTERING CANCER CENTER2UNIV CALIFORNIA2US HEALTH1
Top patents by PatentIndex Score
22 records- 0195US10822389B2Antibody/T-cell receptor chimeric constructs and uses thereofEUREKA THERAPEUTICS INC·Filed 2019·Granted Nov 3, 2020·11 cites·22 claims
- 0294US10464988B2Antibody/T-cell receptor chimeric constructs and uses thereofEUREKA THERAPEUTICS INC·Filed 2018·Granted Nov 5, 2019·16 cites·18 claims
- 0394US10098951B2Antibody/T-cell receptor chimeric constructs and uses thereofEUREKA THERAPEUTICS INC·Filed 2017·Granted Oct 16, 2018·17 cites·46 claims
- 0489US11440952B2Compositions for preventing or treating viral and other microbial infectionsINVISISHIELD TECH LTD·Filed 2021·Granted Sep 13, 2022·3 cites·22 claims
- 0588US11421013B2Antibody/T-cell receptor chimeric constructs and uses thereofEUREKA THERAPEUTICS INC·Filed 2016·Granted Aug 23, 2022·3 cites·20 claims
- 0686US12459988B2Chimeric protein comprising an anti-influenza virus antibody moiety and a mucoadhesive peptide fragment for preventing or treating influenza infectionsINVISISHIELD TECH LTD·Filed 2024·Granted Nov 4, 2025·1 cites·26 claims
- 0782US10301388B2Antibody agents specific for human CD19 and uses thereofEUREKA THERAPEUTICS INC·Filed 2017·Granted May 28, 2019·2 cites·19 claims
- 0881US11613573B2Chimeric antibody/T-cell receptor constructs and uses thereofEUREKA THERAPEUTICS INC·Filed 2018·Granted Mar 28, 2023·1 cites·19 claims
- 0979US2022348629A1Antibody/t-cell receptor chimeric constructs and uses thereofEUREKA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1078US2025361286A1Antibody/t-cell receptor chimeric constructs and uses thereofEUREKA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1175US11976105B2Antibody/T-cell receptor chimeric constructs and uses thereofEUREKA THERAPEUTICS INC·Filed 2021·Granted May 7, 2024·0 cites·20 claims
- 1274US2025011463A1Constructs targeting prostate-specific membrane antigen (psma) and uses thereofEUREKA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1370US12460193B2Compositions for preventing or treating coronavirus infectionsINVISISHIELD TECH LTD·Filed 2024·Granted Nov 4, 2025·0 cites·30 claims
- 1467US2025281538A1Compositions targeting gpc2 and gpc3 and their use for treating solid tumorsUS HEALTH·Filed 2023·Application pending·0 cites
- 1566US11981742B2Antibody agents specific for human CD19 and uses thereofEUREKA THERAPEUTICS INC·Filed 2019·Granted May 14, 2024·0 cites·16 claims
- 1662US2023141962A1Compositions for preventing or treating viral and other microbial infectionsINVISISHIELD TECH LTD·Filed 2022·Application pending·0 cites
- 1761US11993661B2Constructs targeting prostate-specific membrane antigen (PSMA) and uses thereofEUREKA THERAPEUTICS INC·Filed 2019·Granted May 28, 2024·0 cites·25 claims
- 1854US2023374140A1Compositions targeting ndc80/mhc complexes and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Application pending·0 cites
- 1951US2023293687A1T cells and chimeric stimulating receptors and uses thereofEUREKA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2049US2022267420A1Foxp3 targeting agent compositions and methods of use for adoptive cell therapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Application pending·0 cites
- 2147US7087433B27SK RNA regulated transcriptionUNIV CALIFORNIA·Filed 2002·Granted Aug 8, 2006·0 cites·12 claims
- 2240US2006239976A175K RNA regulated transcriptionUNIV CALIFORNIA·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Zhiyuan Yang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →